Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?

about

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification.The positivity of G-protein-coupled receptor-30 (GPR 30), an alternative estrogen receptor is not different between type 1 and type 2 endometrial cancer.

P2860

Q46764265-E80CFA8A-26DE-4A3E-80EB-F73B6A27D5B7 Q47109592-B7762BF4-7241-4783-BA07-9C7190E30456

P2860

Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?

Item

http://www.wikidata.org/entity/Q37702297

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Is the positivity of estrogen ...... and type 2 endometrial cancer?

@en

Is the positivity of estrogen ...... and type 2 endometrial cancer?

@nl

type

Item

label

Is the positivity of estrogen ...... and type 2 endometrial cancer?

@en

Is the positivity of estrogen ...... and type 2 endometrial cancer?

@nl

prefLabel

Is the positivity of estrogen ...... and type 2 endometrial cancer?

@en

Is the positivity of estrogen ...... and type 2 endometrial cancer?

@nl

P1476

Is the positivity of estrogen ...... and type 2 endometrial cancer?

@en

P2093

Fang Shen

http://www.w3.org/2001/XMLSchema#string

Jingxin Ding

http://www.w3.org/2001/XMLSchema#string

Qi Chen

http://www.w3.org/2001/XMLSchema#string

Yifei Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Increased risk of endometrial carcinoma among users of conjugated estrogens

Distribution of estrogen and progesterone receptors isoforms in endometrial cancer.

Two pathogenetic types of endometrial carcinoma.

Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.

Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.

Type I and II endometrial cancers: have they different risk factors?

Progesterone receptor isoform identification and subcellular localization in endometrial cancer

Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004.

Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study.

The prevalence of endometrial cancer in pre- and postmenopausal Chinese women.

P304

506-511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.13471

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27888807

http://www.w3.org/2001/XMLSchema#string

P932

5352172

http://www.w3.org/2001/XMLSchema#string

Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?

about

P2860

P2860

Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932